Vitrolife AB Overview
Pro stress-test →Vitrolife AB is a Swedish medical device and biotechnology company that develops and distributes specialized products for assisted reproduction and fertility treatment. Founded in 1989 and headquartered in Gothenburg, the company serves IVF clinics globally with innovative solutions ranging from sperm processing and embryo transfer systems to genetic testing services, addressing a critical market need in reproductive health.
Strategic Profile
Pro stress-test →Vitrolife maintains a global footprint with revenue generation across EMEA (Europe, Middle East, Africa), Americas, and Asia-Pacific regions, with EMEA representing the largest revenue contributor. The company's competitive advantage lies in its integrated portfolio of consumables, imaging systems, and laboratory equipment that enhance fertility treatment outcomes, positioning it as a specialized leader in the high-growth assisted reproduction market.
Competitive Landscape
Pro stress-test →Vitrolife operates in a specialized niche with limited direct competitors. Key competitors include Laborie Medical Technologies and other regional players, but Vitrolife's integrated product ecosystem and global distribution network provide differentiation. The assisted reproduction market remains fragmented with room for consolidation.
Industry Context
Vitrolife AB operates in Medical Devices & Biotechnology (Assisted Reproduction).
Key facts
Founded: 1989 · Headquarters: Gothenburg, Sweden · Employees: 1,116 · Revenue: $350M · Market cap: $1.39B